AC Immune SA
ACIU
$2.81
$0.030.92%
NASDAQ
| 06/30/2025 | 06/30/2025 | 06/30/2025 | 03/31/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -21.35% | -21.35% | -21.35% | -17.67% | -17.67% |
| Total Depreciation and Amortization | 10.93% | 10.93% | 10.93% | 13.01% | 13.01% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 42.59% | 42.59% | 42.59% | 260.03% | 260.03% |
| Change in Net Operating Assets | 218.00% | 218.00% | 218.00% | -110.03% | -110.03% |
| Cash from Operations | 9.66% | 9.66% | 9.66% | -409.75% | -409.75% |
| Capital Expenditure | -12.29% | -12.29% | -12.29% | -292.88% | -292.88% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 679.30% | 679.30% | 679.30% | 188.64% | 188.64% |
| Cash from Investing | 759.57% | 759.57% | 759.57% | 177.31% | 177.31% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -0.79% | -0.79% | -0.79% | -47.95% | -47.95% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 200.00% | 200.00% | 200.00% | -400.00% | -400.00% |
| Cash from Financing | -4.32% | -4.32% | -4.32% | -27.95% | -27.95% |
| Foreign Exchange rate Adjustments | -822.16% | -822.16% | -822.16% | -113.50% | -113.50% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 138.49% | 138.49% | 138.49% | -513.10% | -513.10% |